Summit Therapeutics (SMMT) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.76
-0.53
-0.3
-0.08

Details

Expected EPS
-0.257639
Actual EPS
N/A
Surprise EPS
0.26
Surprise Percent
+100%

Description

Summit Therapeutics (SMMT) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts